乳腺癌表观遗传调节方面的进展
Xiao Liu1, Xin Wu1, Jianan Ding1
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Chinese medical journal
|December 17, 2025
概括
像基因组修饰和长非编码RNAs (lncRNAs) 这样的表观遗传机制在乳腺癌进化中至关重要,影响基因表达和耐药性. 针对这些表观遗传脆弱性,为乳腺癌提供了新的治疗策略.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 乳腺癌的进展涉及复杂的瘤环境相互作用.
- 表观遗传机制调节基因表达而不改变DNA序列.
- 关键的表观遗传调节者包括组质子修饰,lncRNA和染色质结构.
研究的目的:
- 总结目前对乳腺癌表观遗传机制的理解.
- 突出表观遗传学,新陈代谢和环境因素之间的相互作用.
- 审查乳腺癌新兴的表观遗传向疗法.
主要方法:
- 对表观遗传机制的审查:基因组修饰,lncRNAs,染色质结构.
- 讨论代谢物在表观遗传调节中的作用.
- 探索表观遗传学在复制启动及其与基因组改变的联系.
主要成果:
- 失调的表观遗传学有助于乳腺癌的发病,转移和耐药性.
- 代谢状态和环境线索影响表观遗传修饰.
- 由表观遗传学驱动的异常复制启动赋予了生长优势和抵抗力.
结论:
- 表观遗传机制是乳腺癌发展和进展的核心.
- 针对表观遗传脆弱性提出了有前途的治疗途径.
- 需要进一步的研究来克服当前表观遗传疗法的局限性.
相关概念视频
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K


